Literature DB >> 26491152

Low-Level Expression of the E1B 20-Kilodalton Protein by Adenovirus 14p1 Enhances Viral Immunopathogenesis.

Jay R Radke1, Sherri L Yong2, James L Cook3.   

Abstract

Adenovirus 14p1 (Ad14p1) is an emergent variant of Ad serotype 14 (Ad14) that has caused increased severity of respiratory illnesses during globally distributed outbreaks, including cases of acute respiratory distress syndrome and death. We found that human cell infection with Ad14p1 results in markedly decreased expression of the E1B 20-kilodalton (20K) protein compared to that with infection with wild-type (wt) Ad14. This reduced Ad14p1 E1B 20K expression caused a loss-of-function phenotype of Ad-infected cell corpses that, in contrast to cells infected with wt Ad14, either failed to repress or increased NF-κB-dependent, proinflammatory cytokine responses of responder human alveolar macrophages. A small-animal model of Ad14-induced lung infection was used to test the translational relevance of these in vitro observations. Intratracheal infection of Syrian hamsters with Ad14p1 caused a marked, patchy bronchopneumonia, whereas hamster infection with wt Ad14 caused minimal peribronchial inflammation. These results suggest that this difference in E1B 20K gene expression during Ad14p1 infection and its modulating effect on the interactions between Ad14-infected cells and the host innate immune response could explain the increased immunopathogenic potential and associated increase in clinical illness in some people infected with the Ad14p1 outbreak strain.IMPORTANCE We previously reported that Ad-infected human cells exhibit E1B 19K-dependent repression of virally induced, NF-κB-dependent macrophage cytokine responses (J. R. Radke, F. Grigera, D. S. Ucker, and J. L. Cook, J Virol 88:2658-2669, 2014, http://dx.doi.org/10.1128/JVI.02372-13). The more virulent, emergent strain of Ad14, Ad14p1, causes increased cytopathology in vitro, which suggested a possible E1B 20K defect. Whether there is a linkage between these observations was unknown. We show that there is markedly reduced expression of E1B 20K in Ad14p1-infected human cells and that this causes an increased proinflammatory cytokine response of human alveolar macrophages and more severe inflammatory lung disease in infected hamsters. This is the first evidence of a clinical relevance of differential expression of the small Ad E1B gene product. The results suggest that there is a low, critical threshold of E1B 19/20K expression that is needed for viral replication and infection transmission but that a higher level of E1B 19/20K expression is required for the usual repression and control of the Ad-triggered host innate immune response.
Copyright © 2015, American Society for Microbiology. All Rights Reserved.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26491152      PMCID: PMC4702539          DOI: 10.1128/JVI.01790-15

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  32 in total

1.  Specific recognition of apoptotic cells reveals a ubiquitous and unconventional innate immunity.

Authors:  Marija Cvetanovic; Justin E Mitchell; Vimal Patel; Benjamin S Avner; Yan Su; Paul T van der Saag; Pamela L Witte; Stefano Fiore; Jerrold S Levine; David S Ucker
Journal:  J Biol Chem       Date:  2006-05-17       Impact factor: 5.157

2.  Genetic identification of adenovirus type 5 genes that influence viral spread.

Authors:  T Subramanian; S Vijayalingam; G Chinnadurai
Journal:  J Virol       Date:  2006-02       Impact factor: 5.103

3.  A new hamster model for adenoviral vaccination.

Authors:  R N Hjorth; G M Bonde; W A Pierzchala; S K Vernon; F P Wiener; M H Levner; M D Lubeck; P P Hung
Journal:  Arch Virol       Date:  1988       Impact factor: 2.574

4.  Functional complementation of the adenovirus E1B 19-kilodalton protein with Bcl-2 in the inhibition of apoptosis in infected cells.

Authors:  S K Chiou; C C Tseng; L Rao; E White
Journal:  J Virol       Date:  1994-10       Impact factor: 5.103

5.  Syrian hamster as a permissive immunocompetent animal model for the study of oncolytic adenovirus vectors.

Authors:  Maria A Thomas; Jacqueline F Spencer; Marie C La Regina; Debanjan Dhar; Ann E Tollefson; Karoly Toth; William S M Wold
Journal:  Cancer Res       Date:  2006-02-01       Impact factor: 12.701

6.  Properties of the adenovirus type 40 E1B promoter that contribute to its low transcriptional activity.

Authors:  V Mautner; A Bailey; V Steinthorsdottir; R Ullah; A Rinaldi
Journal:  Virology       Date:  1999-12-05       Impact factor: 3.616

7.  Pathogenesis of adenovirus type 5 pneumonia in cotton rats (Sigmodon hispidus).

Authors:  G A Prince; D D Porter; A B Jenson; R L Horswood; R M Chanock; H S Ginsberg
Journal:  J Virol       Date:  1993-01       Impact factor: 5.103

8.  Mutations in the gene encoding the adenovirus early region 1B 19,000-molecular-weight tumor antigen cause the degradation of chromosomal DNA.

Authors:  E White; T Grodzicker; B W Stillman
Journal:  J Virol       Date:  1984-11       Impact factor: 5.103

9.  Deletion of the gene encoding the adenovirus 5 early region 1b 21,000-molecular-weight polypeptide leads to degradation of viral and host cell DNA.

Authors:  S Pilder; J Logan; T Shenk
Journal:  J Virol       Date:  1984-11       Impact factor: 5.103

10.  STAT2 Knockout Syrian Hamsters Support Enhanced Replication and Pathogenicity of Human Adenovirus, Revealing an Important Role of Type I Interferon Response in Viral Control.

Authors:  Karoly Toth; Sang R Lee; Baoling Ying; Jacqueline F Spencer; Ann E Tollefson; John E Sagartz; Il-Keun Kong; Zhongde Wang; William S M Wold
Journal:  PLoS Pathog       Date:  2015-08-20       Impact factor: 6.823

View more
  9 in total

1.  Characterization of Viral miRNAs during Adenovirus 14 Infection and Their Differential Expression in the Emergent Strain Adenovirus 14p1.

Authors:  Eric R McIndoo; Hailey M Burgoyne; Hyung-Sup Shin; Jay R Radke
Journal:  Viruses       Date:  2022-04-26       Impact factor: 5.818

Review 2.  Cytokine Responses to Adenovirus and Adenovirus Vectors.

Authors:  Svetlana Atasheva; Dmitry M Shayakhmetov
Journal:  Viruses       Date:  2022-04-24       Impact factor: 5.818

Review 3.  Mechanisms of pathogenesis of emerging adenoviruses.

Authors:  James Cook; Jay Radke
Journal:  F1000Res       Date:  2017-01-30

4.  Seroprevalence of neutralizing antibodies against adenovirus type 14 and 55 in healthy adults in Southern China.

Authors:  Xuehua Zheng; Xia Rong; Ying Feng; Xikui Sun; Liang Li; Qian Wang; Min Wang; Wenkuan Liu; Chufang Li; Yiyu Yang; Rong Zhou; Jiahai Lu; Liqiang Feng; Ling Chen
Journal:  Emerg Microbes Infect       Date:  2017-06-07       Impact factor: 7.163

5.  Human mastadenovirus-B (HAdV-B)-specific E3-CR1β and E3-CR1γ glycoproteins interact with each other and localize at the plasma membrane of non-polarized airway epithelial cells.

Authors:  Poornima Kotha Lakshmi Narayan; Adriana E Kajon
Journal:  Virology       Date:  2020-04-15       Impact factor: 3.616

6.  The FDA-Approved Drug Nelfinavir Inhibits Lytic Cell-Free but Not Cell-Associated Nonlytic Transmission of Human Adenovirus.

Authors:  Fanny Georgi; Vardan Andriasyan; Robert Witte; Luca Murer; Silvio Hemmi; Lisa Yu; Melanie Grove; Nicole Meili; Fabien Kuttler; Artur Yakimovich; Gerardo Turcatti; Urs F Greber
Journal:  Antimicrob Agents Chemother       Date:  2020-08-20       Impact factor: 5.191

7.  Human Adenovirus Type 4 Comprises Two Major Phylogroups with Distinct Replicative Fitness and Virulence Phenotypes.

Authors:  Camden R Bair; Wei Zhang; Gabriel Gonzalez; Arash Kamali; Daniel Stylos; Jorge C G Blanco; Adriana E Kajon
Journal:  J Virol       Date:  2021-07-07       Impact factor: 6.549

8.  Adenovirus 14p1 Immunopathogenesis during Lung Infection in the Syrian Hamster.

Authors:  Jay R Radke; Hunter J Covert; Fredrick Bauer; Vijayalakshmi Ananthanarayanan; James L Cook
Journal:  Viruses       Date:  2020-05-30       Impact factor: 5.048

Review 9.  Animal Models in Human Adenovirus Research.

Authors:  Luca D Bertzbach; Wing-Hang Ip; Thomas Dobner
Journal:  Biology (Basel)       Date:  2021-12-01
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.